Corneal Crosslinking in Keratoconus and Corneal Ectasia

• Status: Withdrawn
• Trial end date: 2010-10-01
• Target enrollment: 0
• Participant gender: All

Summary

Prospective, randomized, single site to determine the safety and effectiveness of performing corneal collagen cross-linking (CXL) using riboflavin and UVA light in eyes progressive keratoconus or corneal ectasia.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ohio State University
• Treatments: Riboflavin

Criteria

Inclusion Criteria:

• Diagnosis of keratoconus with documented progression over the previous 12 months.

• Diagnosis of corneal ectasia

• Must be able to complete all study visits.

Exclusion Criteria:

• Prior corneal surgery in keratoconus group

• Corneal scarring

• Pregnancy